Liposome-mediated gene transfer into human vascular smooth muscle cells
- PMID: 8281638
- DOI: 10.1161/01.cir.89.1.13
Liposome-mediated gene transfer into human vascular smooth muscle cells
Abstract
Background: Complexing recombinant DNA with cationic liposomes is a convenient means of introducing foreign genes into cells (lipofection) and could potentially form the basis for genetically modifying diseased blood vessels in patients. The mechanism of lipofection is incompletely understood, but it is recognized that the degree of successful gene transfer is highly dependent on cell type. To date, there has been no reported experience with lipofection of human vascular smooth muscle cells.
Methods and results: Primary cultures of human vascular smooth muscle cells were transfected under optimized conditions with a plasmid expressing either firefly luciferase (Luc) or nuclear-localized beta-galactosidase (NL-beta-gal). Cells were derived from either normal human internal mammary arteries (n = 6), fragments of primary atherosclerotic plaque (n = 4), or fragments of restenotic lesions (n = 5). Concurrent lipofection of rabbit vascular smooth muscle cells and NIH 3T3 cells was performed as well. Cultures derived from 15 patients all demonstrated positive expression of the reporter gene. Compared with NIH 3T3 cells, however, expression in human vascular smooth muscle cells was markedly reduced: in cells derived from internal mammary artery, Luc expression, normalized for protein content, was 123-fold lower than in NIH 3T3 cells, whereas the proportion of cells expressing NL-beta-gal was 30-fold lower. Luc expression in cells derived from restenotic tissue was significantly greater than from cells derived from primary plaque (P < .03). Within a given population of cells, the mitotic index of cells expressing the recombinant gene was significantly higher than the mitotic index for the total population of cells (P < .05). Finally, cotransfection experiments, in which lipofection of smooth muscle cells was performed using genes for NL-beta-gal and for human growth hormone, showed that among positive transfects, a high proportion of cells (23% to 36%) coexpressed both genes.
Conclusions: The efficiency of successful lipofection in human vascular smooth muscle cells in vitro is low. Transfection appears to be preferentially facilitated in cells derived from restenotic tissue, and specific properties of smooth muscle cells, including growth rates, appear to be critical for successful transfection. Further elucidation of cell properties that promote transfection is required to augment the efficiency of liposome-mediated gene transfer in human vascular cells.
Similar articles
-
Vascular applications of human gene therapy.Semin Interv Cardiol. 1996 Mar;1(1):84-8. Semin Interv Cardiol. 1996. PMID: 9552498 Review.
-
Vascular Applications of Human Gene Therapy.J Thromb Thrombolysis. 1995;1(3):299-302. doi: 10.1007/BF01060740. J Thromb Thrombolysis. 1995. PMID: 10608008
-
Adenovirus-assisted lipofection: efficient in vitro gene transfer of luciferase and cytosine deaminase to human smooth muscle cells.Atherosclerosis. 1996 Jul;124(1):49-60. doi: 10.1016/0021-9150(96)05816-9. Atherosclerosis. 1996. PMID: 8800493
-
Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury.J Clin Invest. 1994 Feb;93(2):652-61. doi: 10.1172/JCI117017. J Clin Invest. 1994. PMID: 8113401 Free PMC article.
-
Smooth muscle cell phenotypes in atherosclerotic lesions.Curr Opin Lipidol. 1999 Dec;10(6):507-13. doi: 10.1097/00041433-199912000-00005. Curr Opin Lipidol. 1999. PMID: 10680044 Review.
Cited by
-
Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure.Gene Ther. 2011 Sep;18(9):867-73. doi: 10.1038/gt.2011.18. Epub 2011 Apr 7. Gene Ther. 2011. PMID: 21472007 Free PMC article.
-
The complex and evolving story of T cell activation to AAV vector-encoded transgene products.Mol Ther. 2011 Jan;19(1):16-27. doi: 10.1038/mt.2010.250. Epub 2010 Nov 30. Mol Ther. 2011. PMID: 21119617 Free PMC article. Review.
-
CRISPR/Cas9 Delivery Mediated with Hydroxyl-Rich Nanosystems for Gene Editing in Aorta.Adv Sci (Weinh). 2019 Apr 20;6(12):1900386. doi: 10.1002/advs.201900386. eCollection 2019 Jun 19. Adv Sci (Weinh). 2019. PMID: 31380173 Free PMC article.
-
Characterization of the nonmuscle myosin heavy chain IIB promoter: regulation by E2F.Gene Expr. 1996;6(1):45-57. Gene Expr. 1996. PMID: 8931991 Free PMC article.
-
Effects of a range of beta2 adrenoceptor agonists on changes in intracellular cyclic AMP and on cyclic AMP driven gene expression in cultured human airway smooth muscle cells.Br J Pharmacol. 1999 Oct;128(3):721-9. doi: 10.1038/sj.bjp.0702829. Br J Pharmacol. 1999. PMID: 10516654 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources